Pharmaceutical Report

Monday, April 23, 2007

Pfizer pares outlook as net falls
By Peter Loftus —Josée Rose contributed to this article.
The Wall Street Journal Europe
23 Apr 2007

Pfizer Inc.’s first- quarter profit dropped 18% on restructuring-and-acquisition costs, while revenue rose 6.2% on stronger sales of cholesterol drug Lipitor and treatments for cancer and smoking cessation. The world’s largest drug maker by sales also... read more...

0 Comments:

Post a Comment

<< Home